The Peptide Center
Register / Sign in

Reference library

Peptide guides

Browse clear, source-aware overviews organized across six areas of study.

85 published guides

  1. metabolic-health5-Amino-1MQWhen a laboratory value changes but patient outcomes remain uncertain.View guide
  2. metabolic-health5-Amino-1MQ / SLU-PP-332Why the same acronym can refer to different molecules, salts, fragments, or blends.View guide
  3. healthy-agingAbaloparatideHow abaloparatide fits into peptide therapeutics, osteoporosis care, and evidence-based bone health.View guide
  4. healthy-agingAfamelanotideAfamelanotide, Melanotan II, and why receptor and indication differences matter.View guide
  5. healthy-agingAlpha-Klotho mAbWhy a compelling cell or animal result is the beginning of a question, not the end of it.View guide
  6. metabolic-healthAOD-9604A framework for evaluating evidence and regulatory claims around an hGH-fragment research compound.View guide
  7. recovery-repairARA-290An overview of erythropoietin-derived peptide research without turning orphan-drug development into a wellness claim.View guide
  8. metabolic-healthATX-304A practical guide to research stage, controls, endpoints, uncertainty, and applicability.View guide
  9. recovery-repairB7-33B7-33 is a scientifically interesting relaxin mimetic, but its evidence remains preclinical.View guide
  10. metabolic-healthBAM15Why a compelling cell or animal result is the beginning of a question, not the end of it.View guide
  11. cognitive-wellnessBDNFPeer review is a quality filter, not a guarantee of truth or clinical applicability.View guide
  12. recovery-repairBPC-157A conservative review of what laboratory findings can and cannot tell us about BPC-157.View guide
  13. metabolic-healthCagrilintideA careful way to separate interest in a molecule from evidence, approval, and product claims.View guide
  14. metabolic-healthCagrilintide / GLP-1A careful way to separate interest in a molecule from evidence, approval, and product claims.View guide
  15. recovery-repairCardiogenWhy the same acronym can refer to different molecules, salts, fragments, or blends.View guide
  16. recovery-repairCartalaxWhy a compelling cell or animal result is the beginning of a question, not the end of it.View guide
  17. performance-vitalityCJC-1295 No DACA framework for evaluating performance claims without treating a biological mechanism as proof of benefit.View guide
  18. performance-vitalityCJC-1295 No DAC / IpamorelinA framework for evaluating performance claims without treating a biological mechanism as proof of benefit.View guide
  19. performance-vitalityCJC-1295 With DACA framework for evaluating performance claims without treating a biological mechanism as proof of benefit.View guide
  20. recovery-repairCurcuminWhy the same acronym can refer to different molecules, salts, fragments, or blends.View guide
  21. cognitive-wellnessDavunetide (NAP)A valuable case study in how a plausible neuroprotective mechanism can fail in a large human trial.View guide
  22. cognitive-wellnessDihexaWhy hepatocyte growth factor / synaptic research does not justify memory or focus promises.View guide
  23. cognitive-wellnessDihexa / Tesofensine / BPC-157Why hepatocyte growth factor / synaptic research does not justify memory or focus promises.View guide
  24. cognitive-wellnessDSIPWhy delta sleep-inducing peptide research is not the same as a proven sleep treatment.View guide
  25. healthy-agingEpithalonA guide to epithalamin/epithalon aging research without turning telomere biology into a longevity promise.View guide
  26. metabolic-healthExenatideWhat exenatide’s long clinical history can—and cannot—tell us about newer incretin peptides.View guide
  27. healthy-agingFLGR242A fast checklist for separating useful research news from overconfident health marketing.View guide
  28. performance-vitalityFollistatin 344Why a compelling cell or animal result is the beginning of a question, not the end of it.View guide
  29. healthy-agingFOXO4-DRIWhy a compelling cell or animal result is the beginning of a question, not the end of it.View guide
  30. recovery-repairGHK-CuHow to read the GHK-Cu literature without turning mechanisms or models into clinical promises.View guide
  31. performance-vitalityGHRP-2How to evaluate claims involving GHRP compounds, biomarkers, body composition, and recovery.View guide
  32. performance-vitalityGHRP-6How to evaluate claims involving GHRP compounds, biomarkers, body composition, and recovery.View guide
  33. recovery-repairGLOWWhy the same acronym can refer to different molecules, salts, fragments, or blends.View guide
  34. metabolic-healthGLP-1 RHow to distinguish an investigational study record from an approved medicine or lawful compounded product.View guide
  35. metabolic-healthGLP-1 SA regulatory guide to branded FDA-approved medicines, compounded preparations, and unapproved products.View guide
  36. metabolic-healthGLP-1 S / SLU-PP-332A regulatory guide to branded FDA-approved medicines, compounded preparations, and unapproved products.View guide
  37. metabolic-healthGLP-1 THow to separate evidence for an FDA-approved branded product from claims about other preparations.View guide
  38. healthy-agingGonadorelinWhy a clinician's off-label discussion is not the same as buying an unapproved product online.View guide
  39. performance-vitalityHexarelinHow to evaluate claims involving GHRP compounds, biomarkers, body composition, and recovery.View guide
  40. healthy-agingHumaninHumanin research is substantial enough for a guide—but not for a therapeutic promise.View guide
  41. performance-vitalityIGF-1 LR3How to evaluate claims involving GHRP compounds, biomarkers, body composition, and recovery.View guide
  42. performance-vitalityIpamorelinQuestions to ask before accepting claims about body composition, recovery, or vitality.View guide
  43. healthy-agingKisspeptinA framework for reviewing a signaling-peptide claim without turning early research into medical guidance.View guide
  44. recovery-repairKLOWWhy the same acronym can refer to different molecules, salts, fragments, or blends.View guide
  45. recovery-repairKPVHow to read KPV gut-skin and inflammation literature without overstating preclinical findings.View guide
  46. metabolic-healthLiraglutideAn evidence-first guide to liraglutide, its approved indications, and the limits of GLP-1 generalization.View guide
  47. healthy-agingLL-37A guide to distinguishing antimicrobial mechanism research from clinical safety or treatment claims.View guide
  48. healthy-agingLL-37 ComplexEvidence-first context for LL-37 Complex: research literacy without treatment promises.View guide
  49. metabolic-healthMazdutideMazdutide’s aliases, mechanism, phase 3 evidence, and jurisdiction-specific status in one careful reference.View guide
  50. recovery-repairMelanotan IIFDA consumer warnings, unapproved status, and why tanning or libido claims are not benign.View guide
  51. cognitive-wellnessMethylene Blue / MethylliberineWhy the same acronym can refer to different molecules, salts, fragments, or blends.View guide
  52. performance-vitalityMK-677How to evaluate claims involving GHRP compounds, biomarkers, body composition, and recovery.View guide
  53. metabolic-healthMOTS-cHow to understand a mitochondrial-derived peptide as an active research topic, not a shortcut to a health claim.View guide
  54. healthy-agingNAD+A framework for reading NAD+ biology, precursor studies, and injectable product marketing side by side.View guide
  55. cognitive-wellnessOxytocinPersonal stories can be real and still fail every standard of evidence appraisal.View guide
  56. cognitive-wellnessPE-22-28A practical guide to research stage, controls, endpoints, uncertainty, and applicability.View guide
  57. healthy-agingPNC-28A practical guide to research stage, controls, endpoints, uncertainty, and applicability.View guide
  58. metabolic-healthPramlintideA plain-language guide to pramlintide, amylin biology, approved use, and evidence boundaries.View guide
  59. healthy-agingPT-141Why a branded FDA-approved medicine for a specific use is not the same as every product labeled PT-141.View guide
  60. cognitive-wellnessSelankA cautious guide to regional approvals, study quality, and claims made in the United States.View guide
  61. cognitive-wellnessSemaxHow to read semax literature and regional regulatory context without turning a mechanism into a treatment promise.View guide
  62. performance-vitalitySermorelinEvaluating sermorelin claims without treating a GH-releasing peptide narrative as proof of benefit.View guide
  63. metabolic-healthSetmelanotideWhy setmelanotide’s indication, genetic eligibility, and safety warnings matter more than its weight-loss headline.View guide
  64. healthy-agingSHLP2SHLP2 has enough biology for a research guide, with a clear warning that treatment evidence is absent.View guide
  65. metabolic-healthSLU-PP-332A practical guide to research stage, controls, endpoints, uncertainty, and applicability.View guide
  66. healthy-agingSS-31Understanding SS-31 as an active mitochondrial-targeting research program—not a shortcut to an energy or aging claim.View guide
  67. metabolic-healthSurvodutideHow to read survodutide’s phase 3 program without confusing development status with approval.View guide
  68. recovery-repairTB-500Why related names do not make research compounds interchangeable with an approved medicine.View guide
  69. healthy-agingTeriparatideA clinical peptide guide to teriparatide, bone formation, and indication-specific evidence.View guide
  70. healthy-agingTesamorelinAn example of why FDA approval for one defined use does not support broader healthy-aging claims.View guide
  71. performance-vitalityTesamorelin / GHRP-2 / MGF / IpamorelinAn example of why FDA approval for one defined use does not support broader healthy-aging claims.View guide
  72. performance-vitalityTesamorelin / IpamorelinAn example of why FDA approval for one defined use does not support broader healthy-aging claims.View guide
  73. performance-vitalityTesamorelin / MGF / IpamorelinAn example of why FDA approval for one defined use does not support broader healthy-aging claims.View guide
  74. metabolic-healthTesofensineWhy the same acronym can refer to different molecules, salts, fragments, or blends.View guide
  75. cognitive-wellnessTesofensine / DihexaWhy hepatocyte growth factor / synaptic research does not justify memory or focus promises.View guide
  76. healthy-agingThymagenWhy the same acronym can refer to different molecules, salts, fragments, or blends.View guide
  77. healthy-agingThymalinA practical guide to research stage, controls, endpoints, uncertainty, and applicability.View guide
  78. healthy-agingThymosin Alpha-1How to evaluate immune-peptide claims while keeping research interest separate from clinical recommendations.View guide
  79. healthy-agingThymosin Alpha-1 ComplexHow to evaluate immune-peptide claims while keeping research interest separate from clinical recommendations.View guide
  80. recovery-repairThymosin beta-4Thymosin beta-4 and TB-500 are not automatically the same molecule: identity, route, and evidence matter.View guide
  81. cognitive-wellnessVasoactive intestinal peptide (VIP)VIP’s broad biology makes it a useful guide to receptor effects, human experiments, and translation limits.View guide
  82. recovery-repairVIP / BPC-157Why the same acronym can refer to different molecules, salts, fragments, or blends.View guide
  83. metabolic-healthWeight Loss BlendA plain-language map of product categories that are often blurred in peptide discussions.View guide
  84. recovery-repairWolverine BlendWhy the same acronym can refer to different molecules, salts, fragments, or blends.View guide
  85. recovery-repairZiconotideZiconotide shows why a peptide can be clinically real while remaining highly specialized and high risk.View guide

Research comparison

Compare cited research context

Compare neutral, source-linked facts - not dosing, protocols, or treatment advice.